Xilio Therapeutics Inc. Gains 125.27%
Wed, Feb 12, 2025 at 07:29 PM
Xilio Therapeutics Inc. (XLO:NASDAQ) shot up at $1.48, representing a gain of 125.3%. On Wed, Feb 12, 2025, XLO:NASDAQ touched a New 2-Week High of $1.48. The stock appeared on our News Catalysts scanner on Wed, Feb 12, 2025 at 12:08 PM in the 'BIOTECH' category. From Thu, Jan 30, 2025, the stock recorded 33.33% Up Days and 30.00% Green Days
About Xilio Therapeutics Inc. (XLO:NASDAQ)
Xilio Therapeutics Inc is a biotechnology company focused on harnessing the immune system to achieve deep and durable clinical responses to improve the lives of patients with cancer.
Top 10 Gainers:
- Athena Technology Acquisition Corp. II Class A (ATEK:NYSE), 400%
- Tivic Health Systems Inc. (TIVC:NASDAQ), 197.87%
- Mynaric AG (MYNA:NASDAQ), 134.32%
- Kindly MD Inc. (KDLY:NASDAQ), 129.37%
- Xilio Therapeutics Inc. (XLO:NASDAQ), 125.27%
- NKGen Biotech Inc. (NKGN:NASDAQ), 121.64%
- Sacks Parente Golf Inc. (SPGC:NASDAQ), 85.17%
- Firefly Neuroscience Inc Com (AIFF:NASDAQ), 54.4%
- Yoshiharu Global Co. (YOSH:NASDAQ), 52.84%
- Genius Group Limited (GNS:NYSEMKT), 48.44%